UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response

Frontiers in immunology, 2021-09, Vol.12, p.738481

2021

Link zum Volltext

Verfügbarkeit prüfen

Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study

Seminars in arthritis and rheumatism, 2013-08, Vol.43 (1), p.55-62

2013

Link zum Volltext

Verfügbarkeit prüfen

Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial

Clinical and experimental rheumatology, 2016-11, Vol.34 (6), p.1038

2016

Link zum Volltext

Verfügbarkeit prüfen

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

Annals of the rheumatic diseases, 2020-01, Vol.79 (1), p.123

2020

Link zum Volltext

Verfügbarkeit prüfen

Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response

Clinical and experimental immunology, 2022-12, Vol.210 (2), p.141-150

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews

Rheumatology (Oxford, England), 2021-12, Vol.60 (12), p.5601-5609

2021

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.851-857

2013

Link zum Volltext

Verfügbarkeit prüfen

European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response

Rheumatology (Oxford, England), 2022-08, Vol.61 (9), p.3799-3807

2022

Link zum Volltext

Verfügbarkeit prüfen

European bio-naïve spondyloarthritis patients initiating TNFi: Time trends in baseline characteristics, treatment retention and response

Rheumatology (Oxford, England), 2021-12

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Annals of the rheumatic diseases, 2014-11, Vol.73 (11), p.1954-1961

2014

Link zum Volltext

Verfügbarkeit prüfen

Synovial fluid detection in intra-articular injections using a bioimpedance probe (BIP) needle—a clinical study

Clinical rheumatology, 2017-06, Vol.36 (6), p.1349-1355

2017

Link zum Volltext

Verfügbarkeit prüfen

Work disability in Finnish patients with rheumatoid arthritis: a 15-year follow-up

Clinical and experimental rheumatology, 2014-01, Vol.32 (1), p.88

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of treatment on the outcome of very early rheumatoid arthritis

Scandinavian journal of rheumatology, 2001, Vol.30 (3), p.143-148

Ritva Peltomaa, Leena Paimela, Tapani Helve, Marjatta Leirisalo-Repo

2001

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis

Clinical rheumatology, 2008-07, Vol.27 (7), p.927-932

2008

Link zum Volltext

Verfügbarkeit prüfen

High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis

Clinical rheumatology, 2018-06, Vol.37 (6), p.1689-1694

2018

Link zum Volltext

Verfügbarkeit prüfen

Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis

Rheumatology international, 2013-11, Vol.33 (11), p.2723-2729

2013

Link zum Volltext

Verfügbarkeit prüfen

Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis

Annals of the rheumatic diseases, 2002-10, Vol.61 (10), p.889-894

2002

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of infliximab in the treatment of rheumatoid arthritis in clinical practice

Clinical and experimental rheumatology, 2008-11, Vol.26 (6), p.1059

2008

Link zum Volltext

Verfügbarkeit prüfen

Increased level of YKL-40 in sera from patients with early rheumatoid arthritis : a new marker for disease activity

Rheumatology international, 2001-07, Vol.20 (5), p.192-196

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of age on 3 year outcome in early rheumatoid arthritis

Journal of rheumatology, 2000-03, Vol.27 (3), p.638

2000

Link zum Volltext

Verfügbarkeit prüfen

The good initial response to therapy with a combination of traditional disease‐modifying antirheumatic drugs is sustained over time: The eleven‐year results of the Finnish rheumatoid arthritis combination therapy trial

Arthritis and rheumatism, 2009-05, Vol.60 (5), p.1222-1231

2009

Link zum Volltext

Verfügbarkeit prüfen

Inadequately low serum levels of steroid hormones in relation to interleukin‐6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis

Arthritis and rheumatism, 2002-03, Vol.46 (3), p.654-662

2002

Link zum Volltext

Verfügbarkeit prüfen

Systemic sclerosis

Duodecim (Helsinki, Finland : 1961), 2013, Vol.129 (19), p.1981

2013

Link zum Volltext

Verfügbarkeit prüfen

Interruption of biological drugs in patients affected with inflammatory diseases

Duodecim (Helsinki, Finland : 1961), 2016, Vol.132 (4), p.369

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(22)
magazinearticle
(2)

Sprache

Englisch
(22)
Finnisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Rheumatology
(19)
Female
(17)
Male
(17)
Middle Aged
(17)
Adult
(15)
Treatment Outcome
(12)
Antirheumatic Agents - Therapeutic Use
(11)
Arthritis, Rheumatoid - Drug Therapy
(11)
Aged
(10)
Rheumatoid Arthritis
(8)
Biological And Medical Sciences
(7)
Diseases Of The Osteoarticular System
(7)
Inflammatory Joint Diseases
(7)
Medical Sciences
(7)
Severity Of Illness Index
(6)
Aged, 80 And Over
(5)
Arthritis, Rheumatoid - Diagnostic Imaging
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response

Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study

Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response

Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response

European bio-naïve spondyloarthritis patients initiating TNFi: Time trends in baseline characteristics, treatment retention and response

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Synovial fluid detection in intra-articular injections using a bioimpedance probe (BIP) needle—a clinical study

Work disability in Finnish patients with rheumatoid arthritis: a 15-year follow-up

Effect of treatment on the outcome of very early rheumatoid arthritis

Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis

High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis

Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis

Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis

Cost-effectiveness of infliximab in the treatment of rheumatoid arthritis in clinical practice

Increased level of YKL-40 in sera from patients with early rheumatoid arthritis : a new marker for disease activity

Effect of age on 3 year outcome in early rheumatoid arthritis

The good initial response to therapy with a combination of traditional disease‐modifying antirheumatic drugs is sustained over time: The eleven‐year results of the Finnish rheumatoid arthritis combination therapy trial

Inadequately low serum levels of steroid hormones in relation to interleukin‐6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis

Systemic sclerosis

Interruption of biological drugs in patients affected with inflammatory diseases

Suchergebnisse filtern